trending Market Intelligence /marketintelligence/en/news-insights/trending/yysl3klfe0l4zvo-4aqtdw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Destiny Pharma chairman to step down; replacement named

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Destiny Pharma chairman to step down; replacement named

Destiny Pharma PLC said Nigel Rudd is stepping down as chairman and a member of its board Dec. 31.

Rudd will be replaced by Nick Rodgers, a nonexecutive director of Destiny Pharma, in the chairman role.

Brighton, U.K.-based Destiny Pharma develops and sells medicines for infectious diseases.